ACTISONO

Ideally, drug treatments should be designed to be as precise and controllable as possible in order to administer the active ingredients at the site of action in the body. This requires new technologies, such as the control of bioactive substances “from a distance”. This is where the Leibniz ScienceCampus “ACTISONO” steps in. The researchers' aim is to use ultrasound to control the activity of drugs and therapeutically active nucleic acids.